HER2-Positive Adenocarcinoma of Gastroesophageal Junction
HER2-positive adenocarcinoma of the gastroesophageal junction (GEJ) is a rare yet aggressive malignancy that requires targeted treatment strategies. This condition is characterized by the overexpression…